Dr. Mansoureh Mousavi

• Managing multiple pharmaceutical projects in the field of Solid Oral Technologies. • Managing projects for several pharmaceutical customers, including large, medium, and small-size companies, on a contract basis to provide comprehensive services of drug development, technology transfer, scale-up production, clinical and commercial manufacturing, analytical testing, and regulatory services. • Building the operational plan, coordinating and tracking project activities in order to allow optimal progress.

• Coordination of research proposals in the field of rare disease, orphan drug, gene therapy, organ transplantation, and cancer immunotherapy • Management of proposals in the framework of the Horizon Europe programme and Italian national programs • Monitoring of technology transfer, dissemination, exploitation, and communication activities between different partners and organizations.

• Specialist in Innovation and deep-tech. entrepreneurship. • specialist in deal sourcing: experienced in identifying potential projects in the field of life science and biotechnology within the various incubators in Europe. • Due diligence expert: assist the Biotech partner in the due diligence phase (IP, market, technology, competition) for upcoming opportunities, through the integration of different sources of information in order to formulate investment recommendations.

• Management of research projects. • Designed and developed low-cost, instrument-free colorimetric sensors for on-field environmental analysis. • Developed novel optical sensing platform and diagnostic kits for DNA and Protein biomarkers. • Demonstrated record in writing scientific articles and presentation of the result in the international conferences.

• Conducted independent research in multi-disciplinary projects in the field of biosensors. • Developed novel, portable nanostructure optical sensors for the detection of cancer biomarkers. • Designed and developed microfluidic chip and diagnostic kits for biomedical applications. • Conducted Clinical Validation of integrated SPR biosensor for detection of urinary miRNA for early diagnosis of acute kidney injury.